Follow
Doğa Gülhan
Doğa Gülhan
Research Fellow, Harvard Medical School
Verified email at hms.harvard.edu
Title
Cited by
Cited by
Year
Measurement of jet fragmentation in PbPb and collisions at TeV
S Chatrchyan, V Khachatryan, AM Sirunyan, A Tumasyan, W Adam, ...
Physical Review C 90 (2), 024908, 2014
429*2014
Erratum to: A hybrid strong/weak coupling approach to jet quenching
J Casalderrey-Solana, DC Gulhan, JG Milhano, D Pablos, K Rajagopal
Journal of High Energy Physics 2015 (9), 1-48, 2015
2502015
Studies of dijet transverse momentum balance and pseudorapidity distributions in pPb collisions at s NN = 5.02 TeV
S Chatrchyan, V Khachatryan, AM Sirunyan, A Tumasyan, W Adam, ...
The European Physical Journal C 74 (7), 1-26, 2014
1982014
Measurement of transverse momentum relative to dijet systems in PbPb and pp collisions at sNN√= 2.76 TeV
CMS collaboration
Springer Verlag, 2016
181*2016
Angular structure of jet quenching within a hybrid strong/weak coupling model
J Casalderrey-Solana, DC Gulhan, JG Milhano, D Pablos, K Rajagopal
Journal of High Energy Physics 2017 (3), 1-69, 2017
1462017
Detecting the mutational signature of homologous recombination deficiency in clinical samples
DC Gulhan, JJK Lee, GEM Melloni, I Cortés-Ciriano, PJ Park
Nature genetics 51 (5), 912-919, 2019
1302019
Immunogenomic profiling determines responses to combined PARP and PD-1 inhibition in ovarian cancer
A Färkkilä, DC Gulhan, J Casado, CA Jacobson, H Nguyen, ...
Nature communications 11 (1), 1-13, 2020
1252020
Predictions for boson-jet observables and fragmentation function ratios from a hybrid strong/weak coupling model for jet quenching
J Casalderrey-Solana, DC Gulhan, JG Milhano, D Pablos, K Rajagopal
Journal of High Energy Physics 2016 (3), 1-63, 2016
1232016
Phase II study of avelumab in patients with mismatch repair deficient and mismatch repair proficient recurrent/persistent endometrial cancer
PA Konstantinopoulos, W Luo, JF Liu, DC Gulhan, C Krasner, JJ Ishizuka, ...
Journal of Clinical Oncology 37 (30), 2786-2794, 2019
1072019
Observation of Medium-Induced Modifications of Jet Fragmentation in Pb-Pb Collisions at Using Isolated Photon-Tagged Jets
AM Sirunyan, A Tumasyan, W Adam, F Ambrogi, E Asilar, T Bergauer, ...
Physical review letters 121 (24), 242301, 2018
702018
Study of jet quenching with isolated-photon+ jet correlations in PbPb and pp collisions at sNN= 5.02 TeV
AM Sirunyan, A Tumasyan, W Adam, F Ambrogi, E Asilar, T Bergauer, ...
Physics Letters B 785, 14-39, 2018
682018
Linked-read analysis identifies mutations in single-cell DNA-sequencing data
CL Bohrson, AR Barton, MA Lodato, RE Rodin, LJ Luquette, ...
Nature genetics 51 (4), 749-754, 2019
592019
Kinematic bias on centrality selection of jet events in pPb collisions at the LHC
N Armesto, DC Gülhan, JG Milhano
Physics Letters B 747, 441-445, 2015
552015
The landscape of somatic mutation in cerebral cortex of autistic and neurotypical individuals revealed by ultra-deep whole-genome sequencing
RE Rodin, Y Dou, M Kwon, MA Sherman, AM D’Gama, RN Doan, ...
Nature neuroscience 24 (2), 176-185, 2021
452021
The origins and genetic interactions of KRAS mutations are allele-and tissue-specific
JH Cook, GEM Melloni, DC Gulhan, PJ Park, KM Haigis
Nature communications 12 (1), 1-14, 2021
432021
Constraining Gluon Distributions in Nuclei Using Dijets in Proton-Proton and Proton-Lead Collisions at
AM Sirunyan, A Tumasyan, W Adam, F Ambrogi, E Asilar, T Bergauer, ...
Physical review letters 121 (6), 062002, 2018
412018
The landscape of mutational mosaicism in autistic and normal human cerebral cortex
RE Rodin, Y Dou, M Kwon, MA Sherman, AM D’Gama, RN Doan, ...
bioRxiv, 2020
102020
Heterogeneity and Clonal Evolution of Acquired PARP Inhibitor Resistance in TP53- and BRCA1-Deficient Cells
A Färkkilä, A Rodríguez, J Oikkonen, DC Gulhan, H Nguyen, ...
Cancer research 81 (10), 2774-2787, 2021
92021
Computational analysis of cancer genome sequencing data
I Cortés-Ciriano, DC Gulhan, JJK Lee, GEM Melloni, PJ Park
Nature Reviews Genetics 23 (5), 298-314, 2022
82022
A Replication stress biomarker is associated with response to gemcitabine versus combined gemcitabine and ATR inhibitor therapy in ovarian cancer
PA Konstantinopoulos, AA da Costa, D Gulhan, EK Lee, SC Cheng, ...
Nature communications 12 (1), 1-8, 2021
52021
The system can't perform the operation now. Try again later.
Articles 1–20